Reduced connexin43 expression in high-grade human brain glioma cells

J Surg Oncol. 1999 Jan;70(1):21-4. doi: 10.1002/(sici)1096-9098(199901)70:1<21::aid-jso4>3.0.co;2-0.

Abstract

Background and objectives: Connexin43 (cx43), a gap junction protein, is implicated in the suppression of tumor cell growth. Numerous cancer cells show a reduction or loss of cx43 expression compared to their normal counterparts. Our previous studies suggest that cx43 expression is decreased in a variety of human brain tumor cell lines. To further investigate the role of cx43 in the development of human gliomas, we performed the present study on human glioma grades I-IV.

Methods: Immunohistochemistry was performed on paraffin-embedded tissue sections of 18 human gliomas to analyze the expression levels of cx43 in different stages of human gliomas.

Results: High levels of cx43 were observed in all normal brain tissue and in glioma grades I and II. In contrast, the expression of cx43 was very weak in grade III gliomas and almost undetectable in grade IV gliomas.

Conclusions: Our data support the hypothesis that reduction of cx43 is involved in the progression of human gliomas.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Astrocytoma / metabolism
  • Astrocytoma / pathology
  • Brain Neoplasms / metabolism*
  • Brain Neoplasms / pathology
  • Connexin 43 / metabolism*
  • Connexins / metabolism
  • Glioblastoma / metabolism
  • Glioblastoma / pathology
  • Glioma / metabolism*
  • Glioma / pathology
  • Humans
  • Immunohistochemistry
  • Paraffin Embedding
  • Tumor Cells, Cultured

Substances

  • Connexin 43
  • Connexins